These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31763715)

  • 1. Ultrasound and magnetic resonance imaging for group stratification and treatment monitoring in the transgenic adenocarcinoma of the mouse prostate model.
    Fagerland ST; Hill DK; van Wamel A; de Lange Davies C; Kim J
    Prostate; 2020 Feb; 80(2):186-197. PubMed ID: 31763715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted MRI for early detection and characterization of prostate cancer in the transgenic adenocarcinoma of the mouse prostate model.
    Hill DK; Kim E; Teruel JR; Jamin Y; Widerøe M; Søgaard CD; Størkersen Ø; Rodrigues DN; Heindl A; Yuan Y; Bathen TF; Moestue SA
    J Magn Reson Imaging; 2016 May; 43(5):1207-17. PubMed ID: 26559017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model.
    Wirtzfeld LA; Wu G; Bygrave M; Yamasaki Y; Sakai H; Moussa M; Izawa JI; Downey DB; Greenberg NM; Fenster A; Xuan JW; Lacefield JC
    Cancer Res; 2005 Jul; 65(14):6337-45. PubMed ID: 16024636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound.
    Singh S; Pan C; Wood R; Yeh CR; Yeh S; Sha K; Krolewski JJ; Nastiuk KL
    BMC Urol; 2015 Sep; 15():97. PubMed ID: 26391476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials.
    Degrassi A; Russo M; Scanziani E; Giusti A; Ceruti R; Texido G; Pesenti E
    Prostate; 2007 Mar; 67(4):396-404. PubMed ID: 17187397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.
    Xuan JW; Bygrave M; Jiang H; Valiyeva F; Dunmore-Buyze J; Holdsworth DW; Izawa JI; Bauman G; Moussa M; Winter SF; Greenberg NM; Chin JL; Drangova M; Fenster A; Lacefield JC
    Cancer Res; 2007 Mar; 67(6):2830-9. PubMed ID: 17363606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An orthotopic prostate cancer model for new treatment development using syngeneic or patient-derived tumors.
    Chaudary N; Wiljer E; Foltz W; Thapa P; Hill RP; Milosevic M
    Prostate; 2024 Jun; 84(9):823-831. PubMed ID: 38606933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.
    Xuan JW; Bygrave M; Valiyeva F; Moussa M; Izawa JI; Bauman GS; Klibanov A; Wang F; Greenberg NM; Fenster A
    Mol Imaging; 2009; 8(4):209-20. PubMed ID: 19728975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).
    Arbab AS; Shankar A; Varma NR; Deeb D; Gao X; Iskander AS; Janic B; Ali MM; Gautam SC
    BMC Med Imaging; 2011 Dec; 11():21. PubMed ID: 22165848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.
    Chiaverotti T; Couto SS; Donjacour A; Mao JH; Nagase H; Cardiff RD; Cunha GR; Balmain A
    Am J Pathol; 2008 Jan; 172(1):236-46. PubMed ID: 18156212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Yeh IT; Reddick RL; Kumar AP
    Prostate; 2009 May; 69(7):755-60. PubMed ID: 19170049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Prostate Cancer Aggressiveness with Hyperpolarized Dual-Agent 3D Dynamic Imaging of Metabolism and Perfusion.
    Chen HY; Larson PEZ; Bok RA; von Morze C; Sriram R; Delos Santos R; Delos Santos J; Gordon JW; Bahrami N; Ferrone M; Kurhanewicz J; Vigneron DB
    Cancer Res; 2017 Jun; 77(12):3207-3216. PubMed ID: 28428273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Performance of the Ultrasound (US) Elastographic Q-Analysis Score Combined With the Prostate Imaging Reporting and Data System for Malignancy Risk Stratification in Prostate Nodules Based on Transrectal US-Magnetic Resonance Imaging Fusion Imaging.
    Ding Z; Ye X; Zhang L; Sun Y; Ni Z; Liu H; Xu J; Dong F
    J Ultrasound Med; 2019 Nov; 38(11):2991-2998. PubMed ID: 30937942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
    Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
    Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive bioluminescent detection of prostate cancer growth and metastasis in a bigenic transgenic mouse model.
    Hsieh CL; Xie Z; Yu J; Martin WD; Datta MW; Wu GJ; Chung LW
    Prostate; 2007 May; 67(7):685-91. PubMed ID: 17342752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A null-mutation in the Znt7 gene accelerates prostate tumor formation in a transgenic adenocarcinoma mouse prostate model.
    Tepaamorndech S; Huang L; Kirschke CP
    Cancer Lett; 2011 Sep; 308(1):33-42. PubMed ID: 21621325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of MRI with a pelvic phased array antenna in the evaluation of the gland and tumor volume of clinically localized prostatic adenocarcinoma].
    Tollon C; Soulié M; Aziza R; Escourrou G; Pontonnier F; Plante P
    Prog Urol; 1998 Apr; 8(2):223-31. PubMed ID: 9615932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
    Jayaprakash P; Ai M; Liu A; Budhani P; Bartkowiak T; Sheng J; Ager C; Nicholas C; Jaiswal AR; Sun Y; Shah K; Balasubramanyam S; Li N; Wang G; Ning J; Zal A; Zal T; Curran MA
    J Clin Invest; 2018 Nov; 128(11):5137-5149. PubMed ID: 30188869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
    Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
    IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.